secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senseonics Holdings, Inc. (SENS)
CIK:        0001616543
Form:       8-K
Filed at:   2025-01-13T23:59:59+00:00
Accession:  0001104659-25-002855
Event type: other_material
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senseonics reports preliminary 2024 revenue of $22.5M, patient base up 56%, cancels reverse stock split meeting
--------------------------------------------------------------------------------

- Preliminary Q4 revenue ~$8.3M; full year 2024 revenue ~$22.5M.
- Patient base grew 56% to ~6,000 global patients; over 1,000 US prescribers in 2024.
- December new patient shipments ~600, highest monthly total; DTC leads doubled in Q4.
- Cash, equivalents, restricted cash ~$74.9M at Dec 31, 2024; operating expenses guided.
- Cancelled special meeting for reverse stock split after share price appreciation; proxies favored split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1616543/000110465925002855/0001104659-25-002855-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1616543/000110465925002855/tm252718d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-002855

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer